NEW YORK, NY--(Marketwire - December 05, 2008) - The Alzheimer's Drug Discovery Foundation (ADDF) announced today that it is providing a Biotechnology Founder's grant of $295,300 to sGC Pharma, Inc., a start-up biotechnology company dedicated to developing a drug to improve cognition and memory in patients with Alzheimer's disease (AD).
